Orchestra BioMed Holdings (OBIO) Preferred Stock Liabilities (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 5 years of Preferred Stock Liabilities data on file, last reported at $2.8 million in Q1 2026.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.7 million, changed N/A from the prior year.
• Preferred Stock Liabilities for Q1 2026 stood at $2.8 million, up from $2.7 million in the prior quarter.
• Over the last five years, Preferred Stock Liabilities for OBIO reached as high as $160.1 million in Q2 2022 and fell as low as $2.7 million in Q4 2025.
• Historically, Preferred Stock Liabilities has averaged $76.8 million across 3 years, with a median of $67.7 million in 2022.
• On a YoY basis, Preferred Stock Liabilities climbed as much as 5.89% in 2022 and fell as far as 57.7% in 2022.
• Year by year, Preferred Stock Liabilities stood at $67.7 million in 2022, then plunged by 95.94% to $2.7 million in 2025, then increased by 1.27% to $2.8 million in 2026.
• Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $2.8 million in Q1 2026, $2.7 million in Q4 2025, and $67.7 million in Q4 2022.